Paul St-Pierre Plamondon lumped the two together as bad news for everything from immigration to health transfer payments.
Revolutionary iPSC line poised to accelerate development of groundbreaking treatments Pluristyx Announces Immediate Availability of GMP-Compliant PSXi013 iPSC Line for Advanced Therapy Development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback